Infectious and immunologic consequences of blood transfusion

Critical Care

Volumn 8, Issue SUPPL. 2, 2004, Pages

  Dellinger, E Patchen ^a   Anaya, Daniel A ^b  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Blood; Immune suppression; Infection; Leukoreduction; Mortality; Transfusion

Indexed keywords

BACTERIAL INFECTION; BACTERIAL TRANSMISSION; BLOOD TRANSFUSION; CANCER RECURRENCE; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; IMMUNOMODULATION; INFECTION; INFECTION RISK; INTENSIVE CARE; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; REVIEW; SENSITIVITY ANALYSIS; SURGERY; SURGICAL MORTALITY; VIRUS INFECTION;

BLOOD TRANSFUSION; COMMUNICABLE DISEASES; COMMUNITY-ACQUIRED INFECTIONS; DISEASE TRANSMISSION, HORIZONTAL; HUMANS; IMMUNE TOLERANCE; INTENSIVE CARE; RISK ASSESSMENT;

EID: 4344638937     PISSN: 13648535     EISSN: None     Source Type: Journal    
DOI: 10.1186/cc2847     Document Type: Review

References (51)

1. Goodnough LT, Brecher ME, Kanter MH, AuBuchon JP: Transfusion medicine. First of two parts-blood transfusion. N Engl J Med 1999, 340:438-447.
2. Ratko TA, Cummings JP, Oberman HA, Crookston KP, DeChristopher PJ, Eastlund DT, Godwin JE, Sacher RA, Yawn DH, Matuszewski KA: Evidence-based recommendations for the use of WBC-reduced cellular blood components. Transfusion 2001, 41:1310-1319.
3. McAlister FA, Clark HD, Wells PS, Laupacis A: Perioperative allogeneic blood transfusion does not cause adverse sequelae in patients with cancer: a meta-analysis of unconfounded studies. Br J Surg 1998, 85:171-178.
4. Opelz G, Sengar DP, Mickey MR, Terasaki PI: Effect of blood transfusions on subsequent kidney transplants. Transplant Proc 1973, 5:253-259.
5. Kahn RA: Diseases transmitted by blood transfusion. Hum Pathol 1983, 14:241-247.
6. US Department of Health and Human Services: Workshop on Bacterial Contamination of Platelets. Bethesda: FDA, Center for Biologics Evaluation and Research; 24 September 1999. [http://www.fda.gov/cber/minutes/bact092499.pdf]
7. Kuehnert MJ, Roth VR, Haley NR, Gregory KR, Elder KV, Schreiber GB, Arduino MJ, Holt SC, Carson LA, Banerjee SN, Jarvis WR: Transfusion-transmitted bacterial infection in the United States, 1998 through 2000. Transfusion 2001, 41:1493-1499.
8. Aach RD, Kahn RA: Post-transfusion hepatitis: current perspectives. Ann Intern Med 1980, 92:539-546.
9. Shorey J: Southwestern internal medicine conference: the current status of Non-A, Non-B hepatitis. Am J Med Sci 1985, 289:251-261.
10. Cumming PD, Wallace EL, Schorr JB, Dodd RY: Exposure of patients to human immunodeficiency virus through the transfusion of blood components that test antibody-negative. N Engl J Med 1989, 321:941-946.
11. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ: The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study. N Engl J Med 1996, 334:1685-1690.
12. Busch MP, Kleinman SH, Nemo GJ: Current and emerging infectious risks of blood transfusions. JAMA 2003, 289:969-962.
13. Menitove JE: Current risk of transfusion-associated human immunodeficiency virus infection. Arch Pathol Lab Med 1990, 114:330-334.
14. Budka H: Prions and transfusion medicine. Vox Sang 2000, Suppl 2:231-238.
15. Alter M: How is Creutzfeldt-Jakob disease acquired? Neuroepidemiology 2000, 19:55-61.
16. Vamvakas EC, Blajchman MA: Universal WBC reduction: the case for and against. Transfusion 2001, 41:691-712.
17. Centers for Disease Control: West Nile virus infection in organ donor and transplant recipients: Georgia and Florida, 2002. MMWR Morb Mortal Wkly Rep 2002, 51:790-791.
18. Dodd RY: Emerging infections, transfusion safety, and epidemiology. N Engl J Med 2003, 349:1205-1206.
19. Surgenor DM, Wallace EL, Hao SH, Chapman RH: Collection and transfusion of blood in the United States, 1982-1988. N Engl J Med 1990, 322:1646-1651.
20. Wallace EL, Churchill WH, Surgenor DM, An J, Cho G, McGurk S, Murphy L: Collection and transfusion of blood and blood components in the United States, 1992. Transfusion 1995, 35: 802-812.
21. Blajchman MA: Allogeneic blood transfusion, immunomodulation, and postoperative bacterial infection: do we have the answers yet? Transfusion 1997, 37:121-125.
22. Busch ORC, Hop WCJ, Hoynck van Papendrecht MAW, Marquet RL, Jeekel J: Blood transfusions and prognosis in colorectal cancer. N Engl J Med 1993, 329:1354-1356.
23. Houbiers JGA, Brand A, van de Watering LMG, Hermans J, Verwey PJM, Bijnen AB, Pahlplatz P, Schattenkerk ME, Wobbes T, de Vries JE, Klementschitsch P, van de Maas AHM, van de Velde CJH: Randomised controlled trial comparing transfusion of leucocyte-depleted or buffy-coat-depleted blood in surgery for colorectal cancer. Lancet 1994, 344:573-578.
24. Heiss MM, Mempel W, Delanoff C, Jauch K-W, Gabka C, Mempel M, Dieterich H-J, Eissner H-J, Schildberg F-W: Blood transfusion-modulated tumor recurrence: first results of a randomized study of autologous versus allogeneic blood transfusion in colorectal cancer surgery. J Clin Oncol 1994, 12:1859-1867.
25. Vamvakas EC: Transfusion-associated cancer recurrence and postoperative infection: meta-analysis of randomized, controlled clinical trials. Transfusion 1996, 36:175-186.
26. Blajchman MA: Immunomodulatory effects of allogeneic blood transfusions: clinical manifestations and mechanisms. Vox Sang 1998, Suppl 2:315-319.
27. van de Watering LMG, Hermans J, Houbiers JGA, van den Broek PJ, Bouter H, Boer F, Harvey MS, Huysmans HA, Brand A: Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery: a randomized clinical trial. Circulation 1998, 97:562-568.
28. Blajchman MA, Dzik S, Vamvakas EC, Sweeney J, Snyder EL: Clinical and molecular basis of transfusion-induced immunomodulation: summary of the proceedings of a state-of-the-art conference. Transfus Med Rev 2001, 15:108-135.
29. Hebert PC, Fergusson D, Blajchman MA, Wells GA, Kmetic A, Coyle D, Heddle N, Germain M, Goldman M, Toye B, Schweitzer I, vanWalraven C, Devine D, Sher GD: Clinical outcomes following institution of the Canadian universal leukoreduction program for red blood cell transfusions. JAMA 2003, 289:1941-1949.
30. Dzik WH, Anderson JK, O'Neill EM, Assmann SF, Kalish LA, Stowell CP: A prospective, randomized clinical trial of universal WBC reduction. Transfusion 2002, 42:1114-1122.
31. Baron JF, Gourdin M, Bertrand M, Mercadier A, Delort J, Kieffer E, Coriat P: The effect of universal leukodepletion of packed red blood cells on postoperative infections in high-risk patients undergoing abdominal aortic surgery. Anesth Analg 2002, 94: 529-537.
32. Vamvakas EC: WBC-containing allogeneic blood transfusion and mortality: a meta-analysis of randomized controlled trials. Transfusion 2003, 43:963-973.
33. Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR, Hospital Infection Control Practices Advisory Committee: Guideline for prevention of surgical site infection, 1999. Infect Control Hosp Epidemiol 1999, 20:250-278.
34. Agarwal N, Murphy JG, Cayten CG, Stahl WM: Blood transfusion increases the risk of infection after trauma. Arch Surg 1993, 128:171-176.
35. Dellinger EP, Oreskovich MR, Wertz MJ, Hamasaki V, Lennard ES: Risk of infection following laparotomy for penetrating abdominal injury. Arch Surg 1984, 119:20-27.
36. Olsen MA, Sundt TM, Lawton JS, Damiano RJ Jr, Hopkins-Broyles D, Lock-Buckley P, Fraser VJ: Risk factors for leg harvest surgical site infections after coronary artery bypass graft surgery. J Thorac Cardiovasc Surg 2003, 126:992-999.
37. Tang R, Chen HH, Wang YL, Changchien CR, Chen JS, Hsu KC, Chiang JM, Wang JY: Risk factors for surgical site infection after elective resection of the colon and rectum: a single-center prospective study of 2,809 consecutive patients. Ann Surg 2001, 234:181-189.
38. Ikuta S, Miki C, Hatada T, Inoue Y, Araki T, Tanaka K, Tonouchi H, Kusunoki M: Allogenic blood transfusion is an independent risk factor for infective complications after less invasive gastrointestinal surgery. Am J Surg 2003, 185:188-193.
39. Hill GE, Frawley WH, Griffith KE, Forestner JE, Minei JP: Allogeneic blood transfusion increases the risk of postoperative bacterial infection: a meta-analysis. J Trauma 2003, 54:908-914.
40. Jensen LS, Andersen AJ, Christiansen PM, Hokland P, Juhl CO, Madsen G, Mortensen J, Moller-Nielsen C, Hanberg-Sorensen F, Hokland M: Postoperative infection and natural killer cell function following blood transfusion in patients undergoing elective colorectal surgery. Br J Surg 1992, 79:513-516.
41. Jensen LS, Kissmeyer-Nielsen P, Wolff B, Qvist N: Randomised comparison of leucocyte-depleted versus buffy-coat-poor blood transfusion and complications after colorectal surgery. Lancet 1996, 348:841-845.
42. Thomas D, Wareham K, Cohen D, Hutchings H: Autologous blood transfusion in total knee replacement surgery. Br J Anaesth 2001, 86:669-673.
43. Wong JC, Torella F, Haynes SL, Dalrymple K, Mortimer AJ, McCollum CN: Autologous versus allogeneic transfusion in aortic surgery: a multicenter randomized clinical trial. Ann Surg 2002, 235:145-151.
44. Farrer A, Spark JI, Scott DJ: Autologous blood transfusion: the benefits to the patient undergoing abdominal aortic aneurysm repair. J Vasc Nurs 1997, 15:111-115.
45. Newman JH, Bowers M, Murphy J: The clinical advantages of autologous transfusion. A randomized, controlled study after knee replacement. J Bone Joint Surg Br 1997, 79:630-632.
46. Titlestad IL, Ebbesen LS, Ainsworth AP, Lillevang ST, Qvist N, Georgsen J: Leukocyte-depletion of blood components does not significantly reduce the risk of infectious complications. Results of a double-blinded, randomized study. Int J Colorectal Dis 2001, 16:147-153.
47. Wallis JP, Chapman CE, Orr KE, Clark SC, Forty JR: Effect of WBC reduction of transfused RBCs on postoperative infection rates in cardiac surgery. Transfusion 2002, 42:1127-1134.
48. Tartter PI, Mohandas K, Azar P, Endres J, Kaplan J, Spivack M: Randomized trial comparing packed red cell blood transfusion with and without leukocyte depletion for gastrointestinal surgery. Am J Surg 1998, 176:462-466.
49. Vamvakas EC: Meta-analysis of randomized controlled trials investigating the risk of postoperative infection in association with white blood cell-containing allogeneic blood transfusion: the effects of the type of transfused red blood cell product and surgical setting. Transfus Med Rev 2002, 16:304-314.
50. US Department of Health and Human Services Advisory Committee on Blood Safety and Availability. Blood Safety Resolution: January 2001. [http://www.hhs.gov/bloodsafety/resolutions/resjan01.html]
51. Corwin HL, AuBuchon JP: Is leukoreduction of blood components for everyone? JAMA 2003, 289:1993-1955.